Prenatal Monitoring Devices Patent Landscape Analysis Report 2026 Edition

Prenatal Monitoring Devices Market Size, Growth Trends, and Industry Outlook

Market growth is driven by the rising share of high-risk pregnancies, which raises the number of women needing continuous fetal heart rate and maternal vital sign surveillance. Hypertensive disorders affect roughly 5 to 10 percent of pregnancies worldwide, and the WHO estimates that around 2 million stillbirths occur each year.

North America holds the leading regional position because reimbursement for remote and non-stress testing is established and electronic fetal monitoring is used in nearly all US hospital births. This high baseline use creates steady replacement demand for wireless and patch-based systems that free patients from belts and cables. Asia Pacific records the fastest adoption as China and India expand maternity infrastructure, which explains why filings from that region are rising.

Installed-base evidence points to a shift toward wireless hardware. The FDA clearance of the Nuvo INVU system for remote non-stress testing and of GE HealthCare's Novii for wireless monitoring shows that regulators accept signal quality from abdominal sensors. Hospitals that adopt these systems gain shorter set-up time and fewer repeat attachments, and this raises demand for the sensor and algorithm patents described in this report.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Prenatal Monitoring Devices Patent Filing Trends and Innovation Activity

Prenatal monitoring devices attract steady patent filing from medical technology majors, ultrasound specialists, wearable start-ups and university spin-outs. Filings concentrate on electrode design, signal separation of fetal and maternal ECG, ultrasound transducer arrays and cloud-connected interpretation software.

The dataset contains more than 11,500 patent families, with filing activity peaking between 2021 and 2024. Growth in that window reflects the pandemic-era push toward remote obstetric care and the maturing of machine-learning methods for trace analysis.

Rising demand for home and wireless fetal surveillance has translated directly into patent filings for wearable sensors and automated interpretation.

Scope of the Prenatal Monitoring Devices Patent Landscape Analysis Report

The report covers patents on fetal heart rate monitors, cardiotocography systems, Doppler ultrasound transducers, non-invasive fetal ECG, wearable and patch-based maternal-fetal monitors and remote home prenatal monitoring kits. It also covers maternal vital sign and preeclampsia monitoring devices used during pregnancy and labour.

Software claims on fetal heart trace classification, decision support and tele-obstetrics platforms fall inside the scope. Invasive intrapartum devices such as fetal scalp electrodes are included where claims relate to signal acquisition.

Assignees analysed include medical technology companies, ultrasound and patient monitoring manufacturers, digital health start-ups, universities and research institutes, and hospital groups holding granted patents and pending applications.

Global Prenatal Monitoring Devices Patent Landscape Analysis

Prenatal Monitoring Devices Patent Filing Trend Analysis

Annual patent filings in prenatal monitoring devices grew at an estimated 9 to 11 percent per year between 2020 and 2024. Remote care adoption, miniaturised analogue front-end chips and the availability of labelled fetal heart rate datasets drove this increase.

Grants in 2025 exceeded 380, with a rising share covering AI-based trace interpretation and adhesive sensor patches. Publication lags of 18 months mean that 2025 and 2026 filings continue to appear in the data.

Leading Companies and Assignee Analysis in the Prenatal Monitoring Devices Patent Landscape

Geographic Analysis of Prenatal Monitoring Devices Patent Activity

The report assesses patent activity across major jurisdictions, including:

• United States
• Europe
• China
• Japan
• South Korea
• India
• International and WIPO filings

China leads in filing volume, supported by a large domestic manufacturer base including Edan and a high national birth count. The United States follows with the highest share of granted software and wearable claims, and Europe ranks third with strong activity from Philips, Arjo and university groups.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Prenatal Monitoring Devices Technology Segmentation and Innovation Areas

The report segments patent activity by the following technology clusters:

• Cardiotocography and Doppler ultrasound transducers
• Non-invasive fetal ECG electrodes and signal separation
• Wearable and patch-based maternal-fetal sensors
• Remote and home prenatal monitoring platforms
• AI interpretation of fetal heart traces

Among these, cardiotocography and Doppler ultrasound hold the largest share of patent families because of the large installed base of hospital monitors.

Competitive Landscape and Emerging Trends in the Prenatal Monitoring Devices Market

Competition combines hospital monitor incumbents with focused digital health entrants. GE HealthCare, Koninklijke Philips, Arjo (Huntleigh Sonicaid) and Edan defend transducer and telemetry claims, while Nuvo Group and Bistos build around patches and handheld formats. Mindray has extended its position through the Neoventa fetal ECG ST analysis portfolio.

Companies are focusing on:

• Fetal ECG extraction from abdominal electrodes
• Adhesive patch and wireless sensor design
• Doppler transducer array improvements
• Uterine activity and contraction sensing
• Machine-learning classification of fetal heart traces
• Preeclampsia and blood pressure monitoring in pregnancy
• Cloud-based remote surveillance and tele-obstetrics

Emerging innovation themes include multi-sensor patches that combine fetal ECG, maternal blood pressure and oxygen saturation, and explainable models that flag abnormal decelerations in real time. Smartphone-linked home kits for gestational hypertension follow-up and passive acoustic fetal sensing are also gaining claims.

Strategic Insights from the Prenatal Monitoring Devices Patent Landscape

The patent field is moving from hospital-bound cardiotocography toward wearable, connected and algorithm-led monitoring. Incumbents protect transducer and telemetry claims, and newer entrants file on sensors and software, which creates both licensing opportunities and overlap risk in fetal ECG and AI interpretation.

Technology segments, assignee portfolios and jurisdiction trends are analysed across the full dataset. The report provides actionable intelligence supporting:

• Intellectual property strategy
• R&D prioritisation
• Competitive benchmarking
• Technology scouting
• Licensing evaluation
• Partnership assessment
• Investment analysis
• Market entry planning
• Portfolio expansion strategy

Research Methodology for the Prenatal Monitoring Devices Patent Landscape Analysis

Patent data were collected from the USPTO, EPO, WIPO PATENTSCOPE, CNIPA, JPO and KIPO databases, with family consolidation based on priority claims. Queries combined CPC classes A61B 5/344, A61B 5/02411, A61B 8/0866, A61B 5/4362 and G16H 50/20 with keyword sets for fetal, maternal and prenatal monitoring.

Records were screened by title, abstract and claims to remove general ultrasound, neonatal and adult cardiac patents. Assignee names were normalised for subsidiaries and acquisitions, and counts were rounded to reflect search uncertainty.

The market side draws on regulatory databases such as FDA 510(k) and EUDAMED, company filings, clinical trial registries and peer-reviewed obstetrics literature. These inputs confirm commercial relevance for each technology cluster.

Related Reports

Fetal Monitoring Devices Market

Mammography Devices Market

Laparoscopic Devices Market